Cargando…
Non-Small-Cell Lung Cancer Immunotherapy and Sleep Characteristics: The Crossroad for Optimal Survival
Introduction: Non-small-cell lung cancer is still diagnosed at an inoperable stage and systematic treatment is the only option. Immunotherapy is currently considered to be the tip of the arrow as the first-line treatment for patients with a programmed death-ligand 1 ≥ 50. Sleep is known to be an ess...
Autores principales: | Zarogoulidis, Paul, Petridis, Dimitrios, Kosmidis, Christoforos, Sapalidis, Konstantinos, Nena, Lila, Matthaios, Dimitris, Papadopoulos, Vasilis, Perdikouri, Eleni Isidora, Porpodis, Konstantinos, Kakavelas, Paschalis, Steiropoulos, Paschalis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944906/ https://www.ncbi.nlm.nih.gov/pubmed/36810540 http://dx.doi.org/10.3390/diseases11010026 |
Ejemplares similares
-
Immunotherapy and Chemotherapy Versus Sleep Disturbances for NSCLC Patients
por: Zarogoulidis, Paul, et al.
Publicado: (2023) -
Endobronchial Radiofrequency Ablation for pulmonary nodules with Radial-Ebus and Navigation: Pros and Cons
por: Zarogoulidis, Paul, et al.
Publicado: (2023) -
Cryobiopsy for pneumonitis diagnosis in NSCLC immunotherapy
por: Zarogoulidis, Paul, et al.
Publicado: (2022) -
Case Report: Endoscopic radiofrequency ablation with radial-EBUS and ROSE
por: Zarogoulidis, Paul, et al.
Publicado: (2023) -
Cryo-Biopsy versus 19G needle versus 22G needle with EBUS-TBNA endoscopy
por: Oikonomidou, Rena, et al.
Publicado: (2022)